spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online May 30, 2007
doi: 10.1242/10.1242/dev.02855

Development 134, 2303-2314 (2007)
Published by The Company of Biologists 2007
This Article
Right arrow Summary Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Page, B. D.
Right arrow Articles by Ferguson, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Page, B. D.
Right arrow Articles by Ferguson, E. L.

EEL-1, a Hect E3 ubiquitin ligase, controls asymmetry and persistence of the SKN-1 transcription factor in the early C. elegans embryo

Barbara D. Page1,2,3,*, Scott J. Diede4, Jennifer R. Tenlen1,5 and Edwin L. Ferguson3,6

1 Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
2 Howard Hughes Medical Institute, Seattle, WA 98109, USA.
3 Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637, USA.
4 Children's Hospital and Regional Medical Center, Department of Hematology and Oncology, Seattle, WA 98105, USA.
5 Molecular and Cellular Biology Program, University of Washington, Seattle, WA 98195, USA.
6 Committee on Developmental Biology, University of Chicago, Chicago, IL 60637, USA.


Figure 1
View larger version (90K):
[in this window]
[in a new window]

  		Fig. 1. Loss of eel-1 enhances efl-1(se1) to a Mex phenotype. The top row contains Nomarski images of terminally developed C. elegans embryos from eel-1(RNAi), efl-1(se1) and efl-1(se1);eel-1(RNAi) mothers incubated at 20°C. Note that eel-1(RNAi) and efl-1(se1) embryos form enclosed pretzel-shaped embryos and appear as wild type. By contrast, efl-1(se1);eel-1(RNAi) embryos do not enclose and fail to elongate. The center row shows comparable embryos stained for pharyngeal muscle to demonstrate that efl-1;eel-1(RNAi) embryos produce an excess of this tissue in comparison with embryos from either single mutant mother. The bottom row contains images of the MED-1:GFP expression pattern at the 15-cell stage. This expression pattern is wild-type in eel-1(RNAi) (n=25 of 25) and efl-1(se1) (n=22 of 23) single-mutant embryos; MED-1:GFP is expressed only in a subset of descendants of the posterior cell of the 2-cell embryo. In efl-1(se1);eel-1(RNAi) embryos (n=25 of 30), MED-1:GFP is ectopically expressed in descendants of the anterior blastomere of the 2-cell embryo. Embryos are oriented with anterior to the left. Scale bar: 10 µm.

 

Figure 2
View larger version (8K):
[in this window]
[in a new window]

  		Fig. 2. Similarities between C. elegans EEL-1 and the human MULE E3 ligases. This diagram illustrates multiple domains shared between EEL-1 and human MULE. Between each domain of similarity, percentages of identity (I) and similarity (S) are noted. The location at which zu462 is predicted to disrupt EEL-1 is indicated (zig-zag line).

 

Figure 3
View larger version (113K):
[in this window]
[in a new window]

  		Fig. 3. Loss of eel-1 disrupts SKN-1 spatial and temporal regulation. Each pair of rows shows SKN-1 staining (above) and corresponding nuclear staining (DAPI, below) of C. elegans embryos at a given stage (2-cell, 4-cell, 12-cell and 28-cell) from a hermaphrodite of indicated genotype incubated at 20°C. Embryos are oriented with anterior to the left. Scale bar: 10 µm.

 

Figure 4
View larger version (30K):
[in this window]
[in a new window]

  		Fig. 4. SKN-1 asymmetry is disrupted in eel-1(-) and efl-1(-);eel-1(-) C. elegans embryos. (A,B) The posterior:anterior ratio (Post/Ant) of nuclear SKN-1 staining was calculated for individual embryos of the given genotype at the 2-cell (A) or 4-cell (B) stage. (C,D) Nuclear SKN-1 staining was quantitated in equivalent blastomeres for pairs of eel-1(RNAi) and wild-type embryos, and the eel-1(-) to wild-type ratio (eel-1/WT) was calculated for the anterior and posterior blastomere(s). Variability was minimized by performing individual comparisons between pairs of embryos from a single slide: 2-cell (C) and 4-cell (D) stage. The mean±s.e.m. is shown.

 

Figure 5
View larger version (58K):
[in this window]
[in a new window]

  		Fig. 5. EEL-1 interacts with SKN-1 in the yeast two-hybrid assay. (A) The level of two-hybrid interactions between C. elegans EEL-1 and SKN-1. The left column indicates the amino acids of EEL-1 fused to the GAL4 DNA-binding domain, and the central column indicates the amino acids of SKN-1 fused to the GAL4 activation domain. The domain structure of EEL-1 is shown in Fig. 2. SKN-1 has 623 amino acid residues, and its DNA-binding domain comprises residues 549-614. The right column shows the level of growth on selective medium when yeast are transformed with the corresponding plasmids. (B) Two-hybrid interaction between EEL-1 and SKN-1.

 

Figure 6
View larger version (76K):
[in this window]
[in a new window]

  		Fig. 6. The C-terminus of SKN-1 targets GFP for degradation in an EEL-1-dependent manner. Wild-type (left) and eel-1(RNAi) (right) 15-cell C. elegans embryos expressing GFP (top row) or GFP:SKN-1(298-623) fusion protein (bottom row) under control of the pie-1 promoter and pie-1 3'UTR. Embryos are oriented with anterior to the left. Scale bar: 10 µm.

 




© The Company of Biologists Ltd 2007